| Question 1 |
| Question 15 | Bioavailability and the factors which affect it |
| Question 15 | Clearance, hepatic extraction ratio and the role of the liver in drug clearance |
| Question 5 | Volume of distribution: definition, measurement and factors affecting it |
| Question 7 | The significance of protein binding in pharmacology |
| Question 5 | Fentanyl vs remifentanil: a discussion of context-sensitive half time. |
| Question 22 | Bioavailability, and the factors which affect it |
| Question 20 | Role of the liver in pharmacokinetics: hepatic clearance and Phase I/II reactions |
| Question 8 | Factors which influence renal drug clearance: drug characteristics |
| Question 12 | Volume of distribution, and factors that influence it. |
| Question 20 | Factors affecting drug absorption from the gastrointestinal tract |
| Question 13 | The effects of critical illness on drug pharmacokinetics |
| Question 13 | |
| Question 11 |
| Question 3 | Renal clearance of drugs, and the effect of this on dosing |
| Question 20 |
| Question 5(p.2) | Bioavailability and factors which influence it |
| Question 8 |
| Question 5(p.2) |
| Question 10 | Maintenance dose and loading dose; and the factors which affect them |
| Question 5(p.2) | |
| Question 4 | Interpreting the measurement of plasma drug concentrations |